Name | Number of supported studies | Average coverage | |
|---|---|---|---|
| endothelial cell | 10 studies | 26% ± 10% | |
| endothelial cell of lymphatic vessel | 8 studies | 21% ± 5% | |
| smooth muscle cell | 7 studies | 18% ± 2% | |
| epithelial cell | 7 studies | 30% ± 14% | |
| fibroblast | 6 studies | 24% ± 6% | |
| connective tissue cell | 5 studies | 25% ± 6% | |
| neuron | 5 studies | 29% ± 15% | |
| glutamatergic neuron | 5 studies | 34% ± 17% | |
| myofibroblast cell | 5 studies | 21% ± 3% | |
| pericyte | 5 studies | 22% ± 6% | |
| natural killer cell | 4 studies | 17% ± 2% | |
| astrocyte | 4 studies | 20% ± 4% | |
| B cell | 3 studies | 19% ± 5% | |
| neural crest cell | 3 studies | 16% ± 1% | |
| GABAergic neuron | 3 studies | 33% ± 8% | |
| abnormal cell | 3 studies | 22% ± 4% | |
| basal cell | 3 studies | 30% ± 10% | |
| goblet cell | 3 studies | 21% ± 6% | |
| oligodendrocyte | 3 studies | 16% ± 0% | |
| enteroendocrine cell | 3 studies | 23% ± 11% |
Tissue | GTEx Coverage | GTEx Average TPM | GTEx Number of samples | TCGA Coverage | TCGA Average TPM | TCGA Number of samples |
|---|---|---|---|---|---|---|
| esophagus | 100% | 6600.02 | 1445 / 1445 | 100% | 35.36 | 183 / 183 |
| liver | 100% | 3637.16 | 226 / 226 | 100% | 28.17 | 406 / 406 |
| ovary | 100% | 6868.24 | 180 / 180 | 100% | 48.70 | 430 / 430 |
| pancreas | 100% | 4990.41 | 328 / 328 | 100% | 38.99 | 178 / 178 |
| stomach | 100% | 5554.54 | 359 / 359 | 100% | 37.48 | 286 / 286 |
| thymus | 100% | 9752.78 | 653 / 653 | 100% | 46.44 | 605 / 605 |
| brain | 100% | 8146.96 | 2640 / 2642 | 100% | 57.68 | 705 / 705 |
| prostate | 100% | 7557.36 | 245 / 245 | 100% | 46.14 | 501 / 502 |
| uterus | 100% | 7486.32 | 170 / 170 | 100% | 45.64 | 458 / 459 |
| lung | 100% | 6349.78 | 577 / 578 | 100% | 39.41 | 1154 / 1155 |
| kidney | 100% | 6723.31 | 89 / 89 | 100% | 39.51 | 898 / 901 |
| intestine | 100% | 6675.60 | 966 / 966 | 100% | 41.53 | 525 / 527 |
| bladder | 100% | 6952.86 | 21 / 21 | 100% | 40.07 | 502 / 504 |
| skin | 100% | 6633.39 | 1808 / 1809 | 100% | 39.65 | 470 / 472 |
| breast | 100% | 6538.27 | 459 / 459 | 99% | 36.65 | 1112 / 1118 |
| adrenal gland | 100% | 5749.99 | 258 / 258 | 99% | 42.79 | 227 / 230 |
| adipose | 100% | 6286.69 | 1204 / 1204 | 0% | 0 | 0 / 0 |
| eye | 0% | 0 | 0 / 0 | 100% | 43.79 | 80 / 80 |
| lymph node | 0% | 0 | 0 / 0 | 100% | 38.69 | 29 / 29 |
| muscle | 100% | 19122.38 | 803 / 803 | 0% | 0 | 0 / 0 |
| spleen | 100% | 8528.52 | 241 / 241 | 0% | 0 | 0 / 0 |
| tonsil | 0% | 0 | 0 / 0 | 100% | 37.60 | 45 / 45 |
| ureter | 0% | 0 | 0 / 0 | 100% | 31.83 | 1 / 1 |
| blood vessel | 100% | 5646.11 | 1333 / 1335 | 0% | 0 | 0 / 0 |
| heart | 100% | 4766.61 | 859 / 861 | 0% | 0 | 0 / 0 |
| peripheral blood | 86% | 2864.03 | 798 / 929 | 0% | 0 | 0 / 0 |
| abdomen | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
| bone marrow | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
| diaphragm | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
| gingiva | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
| nasal cavity | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
| nasopharynx | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
| nose | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
| placenta | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
| spinal column | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
| GO_0032874 | Biological process | positive regulation of stress-activated MAPK cascade |
| GO_0050772 | Biological process | positive regulation of axonogenesis |
| GO_0051645 | Biological process | Golgi localization |
| GO_0007165 | Biological process | signal transduction |
| GO_0007163 | Biological process | establishment or maintenance of cell polarity |
| GO_0051683 | Biological process | establishment of Golgi localization |
| GO_0090168 | Biological process | Golgi reassembly |
| GO_0007409 | Biological process | axonogenesis |
| GO_0034599 | Biological process | cellular response to oxidative stress |
| GO_0036481 | Biological process | intrinsic apoptotic signaling pathway in response to hydrogen peroxide |
| GO_0006468 | Biological process | protein phosphorylation |
| GO_0046777 | Biological process | protein autophosphorylation |
| GO_0006979 | Biological process | response to oxidative stress |
| GO_0090443 | Cellular component | FAR/SIN/STRIPAK complex |
| GO_0070062 | Cellular component | extracellular exosome |
| GO_0005794 | Cellular component | Golgi apparatus |
| GO_0005737 | Cellular component | cytoplasm |
| GO_0042803 | Molecular function | protein homodimerization activity |
| GO_0106310 | Molecular function | protein serine kinase activity |
| GO_0004674 | Molecular function | protein serine/threonine kinase activity |
| GO_0004672 | Molecular function | protein kinase activity |
| GO_0046872 | Molecular function | metal ion binding |
| GO_0005524 | Molecular function | ATP binding |
| GO_0005515 | Molecular function | protein binding |
| Gene name | STK25 |
| Protein name | non-specific serine/threonine protein kinase (EC 2.7.11.1) Serine/threonine-protein kinase 25 (EC 2.7.11.1) (Ste20-like kinase) (Sterile 20/oxidant stress-response kinase 1) (SOK-1) (Ste20/oxidant stress response kinase 1) Serine/threonine kinase 25 |
| Synonyms | YSK1 SOK1 |
| Description | FUNCTION: Oxidant stress-activated serine/threonine kinase that may play a role in the response to environmental stress. Targets to the Golgi apparatus where it appears to regulate protein transport events, cell adhesion, and polarity complexes important for cell migration. . |
| Accessions | ENST00000435225.5 O00506 ENST00000424537.5 ENST00000535007.5 [O00506-3] C9J8E8 ENST00000439101.5 A0A024R4B2 ENST00000436402.5 ENST00000426941.1 ENST00000420551.1 ENST00000401869.5 [O00506-1] ENST00000543554.5 [O00506-3] ENST00000316586.9 [O00506-1] ENST00000423004.5 ENST00000403346.7 [O00506-1] ENST00000440109.5 C9JIH8 ENST00000405883.7 [O00506-2] C9J6L2 C9JDH9 C9JJV0 ENST00000450497.5 ENST00000413760.5 C9J232 C9JFA1 C9JCC0 H7C279 ENST00000442307.5 C9K0M6 E7EM58 A0A0S2Z4Y2 ENST00000405585.5 [O00506-2] A0A0S2Z503 C9JN58 ENST00000429279.5 |